Research.Patient.info
Hemolytic Disease of the Fetus and Newborn research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
This study looks at a new medicine called nipocalimab to help pregnant people whose babies are at risk of a serious blood condition called HDFN. It aims to see if the medicine can stop the baby from developing anaemia while still in the womb.
United States · Argentina · Australia - recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
This study looks at a blood condition called HDFN, which can affect babies during pregnancy or soon after birth. Researchers want to understand the risk of babies getting anaemia (low red blood cells) when their mothers have HDFN, using information collected from medical records.
United States · Australia · Belgium